Engineering biology

Oxford Genetics is a leading synthetic biology company focused on developing novel technologies to overcome the challenges associated with the discovery, development and production of biologics, gene therapies, cell therapies and vaccines.


Our proprietary genomic system enables the precise engineering of DNA, which in combination with our automated platforms, drive the rational design of complex biologics and their associated production processes. With the overarching aim of increasing predictability, robustness and scalability, while lowering cost and human error.

Our Mission

Engineering biology to pioneer better biotherapeutics

At Oxford Genetics, ambition and optimism runs through everything we do. Our company was founded on the belief that there was a better way to create biologics. That pioneering spirit is in our DNA and continues to drive us today. We don’t just develop the best products and technologies for our customers, but also provide the best facilities and environments for our employees.

Newsroom

  • Oxford Genetics Announces New Online Customer Portal for Custom Research Services
  • Oxford Genetics announces adeno-associated virus collaboration with MeiraGTx
  • Oxford Genetics licenses SnapFast™ expression vectors to Twist Bioscience
  • Influenza, the difficulty of producing effective vaccines, and recent innovation in flu vaccines
  • DNA origami: from novelty item to novel applications
  • Genome Editing: One Small Needle for Brian, One Giant Injection For Gene Therapy
  • Protein Engineering Summit
  • British Gene and Cell therapy (BGCT)
  • International Oncolytic Virus Conference